Concepedia

Wendi Hu

WH

Statistics

Publications

17

Citations

1.5K

H-Index

15

Active since

2014

Affiliations

Zhejiang University(Current)

Blood Center of Zhejiang Province

First Affiliated Hospital Zhejiang University

Ministry of Public Health

Chongqing Medical University

Wendi Hu is an author at Zhejiang University specializing in molecular oncology, oncology, and medicine.

Publications per year

2014–2024

17

Publications

17

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

Yunhao Chen, Chuanhui Peng, Junru Chen et al. · Molecular Cancer · 2019 · 671 citations · Full text

, , +17

ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway

Junru Chen, Chaofeng Ding, Yunhao Chen et al. · Cancer Letters · 2020 · 223 citations

, , +16

ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis

Junru Chen, Chaofeng Ding, Yunhao Chen et al. · Oncogenesis · 2020 · 120 citations · Full text

, , +17

Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma

Chengli Du, Xiaoyu Weng, Wendi Hu et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 73 citations · Full text

, , +17

Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma

Weijian Sun, Bin He, Beng Yang et al. · Laboratory Investigation · 2018 · 53 citations · Full text

, , +16

1–5 of 17